Baker Chad R Increases Position in Relx Plc (NYSE:RELX)

Baker Chad R boosted its position in Relx Plc (NYSE:RELX - Free Report) by 50.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 169,025 shares of the technology company's stock after purchasing an additional 56,575 shares during the period. Relx comprises 1.7% of Baker Chad R's investment portfolio, making the stock its 26th biggest position. Baker Chad R's holdings in Relx were worth $8,521,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of RELX. LGT Group Foundation acquired a new stake in Relx during the 4th quarter valued at $257,000. Paradigm Asset Management Co. LLC grew its holdings in Relx by 17.1% during the 4th quarter. Paradigm Asset Management Co. LLC now owns 81,600 shares of the technology company's stock valued at $3,706,000 after buying an additional 11,900 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Relx by 120.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 12,066 shares of the technology company's stock worth $548,000 after purchasing an additional 6,588 shares during the last quarter. Public Employees Retirement System of Ohio boosted its holdings in shares of Relx by 21.4% during the fourth quarter. Public Employees Retirement System of Ohio now owns 162,830 shares of the technology company's stock worth $7,396,000 after purchasing an additional 28,702 shares during the last quarter. Finally, Merit Financial Group LLC grew its position in shares of Relx by 77.7% in the first quarter. Merit Financial Group LLC now owns 11,757 shares of the technology company's stock valued at $593,000 after purchasing an additional 5,139 shares during the period. 15.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. The Goldman Sachs Group assumed coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating for the company. Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. Finally, Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Buy".

Relx Trading Up 1.1%

Relx stock traded up $0.58 during midday trading on Monday, reaching $53.34. The stock had a trading volume of 1,098,360 shares, compared to its average volume of 729,130. Relx Plc has a twelve month low of $43.45 and a twelve month high of $56.33. The stock has a market capitalization of $98.46 billion, a PE ratio of 28.68, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The stock's 50-day simple moving average is $53.29 and its 200 day simple moving average is $50.04.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.